Fig. 4. Ectopic localization of Bmp4+ cells and signaling in the kidney
of the Foxd1 null. At E14.5, Bmp4lacZ expression
is normally limited to the ureter and structures in the interior of the kidney
(A). A Foxd1-null mutant (B) displays weak expression in the interior
of the kidney, but high expression in the capsule (ca). At E12.5 (C,D),
Bmp4lacZ expression is present in the midline of both
Foxd1-null and heterozygous tissue but there is a wider distribution
of expression around the kidneys in the mutant. We confirmed these results at
E12.5 by immunofluorescence with an anti-ß-gal antibody (red cells in
E,F) and GFP expression from the Foxd1GFP allele (green
cells in E,F). Expression of GFP and lacZ did not overlap.
At E18.5, the heterozygous and mutant kidney both displayed similar expression
of Bmp4lacZ (G,H). At E12.5, phospho-Smad1 expression
(brown) is in the pre-tubular aggregates (pa) (I,I'), while weaker
expression is displayed in the condensed mesenchyme on both sides of the UB.
There is no expression in the nascent capsule layer (nca). In the
Foxd1-null (J,J'), phospho-Smad1 expression is strongly
expressed in the pre-tubular aggregates, but there is also expression in the
nascent capsule layer. At E14.5 in wild type (K,K'), phospho-Smad1
expression is in the pre-tubular aggregates, the renal vesicles (rv) and the
UB stalk, but not in the condensed mesenchyme above the UB tips, nor the part
of the UB tips that face the capsule (ca). In the Foxd1 null
(L,L') phospho-Smad1 expression is also in pre-tubular aggregates and
renal vesicles, but these structures are ectopically positioned between the UB
and the capsule. Higher magnification of the bracketed areas in I-L are
displayed (I',J',K',L'). Scale bar: 200 µm for
A,B,G,H,K,L; 100 µm for C-F,I,J; 75 µm for K',L'; 50 µm
for I',J'.